Company Response
U.S. Securities and Exchange Commission (SEC) has not responded to
Timeline
-
U.S. Securities and Exchange Commission (SEC) did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Migdal did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Glazer Capital did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Phoenix Holdings did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Light Street Capital Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Millennium Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Empyrean Capital Partners did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Citadel did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
683 Capital Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Crescent Park Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Makena Capital Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
West Coast Equity Partners did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Weiss Asset Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Park West Asset Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Nasdaq did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Crosslink Capital did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Axon Enterprise did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
Available languages: English -
Open Letter: Cellebrite should not go public without demonstrating human rights compliance
Available languages: English
View full story